Glucose Analyzer 201

Features

• Professional-grade glucose analyzer for point-of-care testing
• Delivers laboratory-quality glucose results in less than 1 minute
• CLIA-waived for professional healthcare use
• Supports diabetes screening, monitoring, and diagnostic evaluations
• Suitable for oral glucose tolerance testing (OGTT) and gestational diabetes screening
• Uses advanced microcuvette technology for reliable testing
• Requires less than 5 µL blood sample volume
• Accepts capillary, venous, and arterial whole blood samples
• Factory calibrated with no coding or recalibration required
• Measurement range: 0–444 mg/dL (0–24.6 mmol/L) plasma equivalent values
• Built-in self-test for quality assurance
• Operates using AC power or 4 AA batteries
• Compact and portable design for use across multiple care settings
• Can be used with multiple patients in professional healthcare environments
• Sold as a Single Piece

Description

The HemoCue® Glucose 201 System is a professional point-of-care glucose testing system designed to deliver laboratory-quality results in healthcare settings. Unlike traditional home glucose meters, this analyzer is intended for professional use and can assist healthcare providers in diabetes screening, monitoring, and diagnostic evaluations. Results are available in less than one minute, helping support timely clinical decision-making.

Using advanced microcuvette technology, the system requires less than 5 µL of blood and can analyze capillary, venous, or arterial whole blood samples. The factory-calibrated design eliminates the need for coding or additional calibration, helping streamline testing procedures while maintaining reliable performance.

Compact and portable, the analyzer can operate using an AC adapter or four AA batteries, making it suitable for physician offices, clinics, hospitals, and other healthcare environments. The HemoCue® Glucose 201 System is CLIA-waived and designed to support compliant testing workflows, including oral glucose tolerance testing (OGTT) and gestational diabetes screening.